Latest News for MEDIF
TORONTO, July 14, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specializing in precision-based cannabinoids, today announced positive results from the Phase II LiBBY (Life's End Benefits of Cannabidiol and Tetrahydrocannabinol) clinical trial evaluating the Company's proprietary oral cannabinoid…
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual and special meeting (the “Meeting”) of holders of common shares (“Shareholders”) held today. There were 389 Shareholders represented…
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual and special meeting (the "Meeting") of holders of common shares ("Shareholders") held today.
Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time).
MediPharm Labs Corp. (LABS:CA) Q1 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for MEDIF.
Senate Trading
No Senate trades found for MEDIF.
U.S. House Trading
No House trades found for MEDIF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.